Search results
...Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of...
Rome Sentinel· 2 days agoCalyx / Invicro, a global leader in providing medical imaging solutions and development services to the clinical research community, today announces a strategic ...
Citi maintains neutral stance on 23andMe with $0.63 target By Investing.com
Investing.com· 6 days agoThe decision comes after the biotechnology company presented early Phase 2 data at the 2024 American...
Alcanza Acquires North Georgia Clinical Research to Expand Opportunities for Research Participation
The Herald-News· 6 days agoWith patient diversity becoming increasingly important to biopharmaceutical stakeholders, Alcanza Clinical Research, a mission-focused investigator site ...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 2 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
Newswise Expert | Anthony B. El-Khoueiry, Keck Medicine of USC
Newswise· 17 hours agoDr. El-Khoueiry has established a national reputation in the area of hepatobiliary cancers clinical research; he is the co-chair of the hepatobiliary cancers ...
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial...
Morningstar· 6 days agoMETIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free ...
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 6 days agoWalgreens has signed a deal with Boehringer Ingelheim to use its community pharmacies as clinical...
Annexon (NASDAQ:ANNX) Shares Down 7.5%
ETF DAILY NEWS· 19 hours agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) traded down 7.5% during trading on Friday . The stock traded as low as $5.44 and last traded at $5.45. 1,658,045 shares were traded during ...
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
Motley Fool via Yahoo Finance· 11 hours agoFor now, the next step will be running a phase 2b trial, which is slated to start in the fourth...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 3 days agoDermavant’s VTAMA has been marketed for adult patients with plaque psoriasis and was first approved...